Cowen and Company’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-702,089
Closed -$6.25K 821
2022
Q4
$6.25K Buy
702,089
+439,110
+167% +$8.69K ﹤0.01% 455
2022
Q3
$13K Buy
262,979
+41,604
+19% +$3.27K ﹤0.01% 402
2022
Q2
$23K Buy
+221,375
New +$52K ﹤0.01% 376

Other funds holding GLS.WS

Cowen and Company's GLS.WS Position: Q1 2023 in Review

Cowen and Company sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q1 2023, closing a stake of 702,089 shares — an estimated $6.25K sold.

Cowen and Company first reported a position in GLS.WS in Q2 2022 and held it in 3 quarters. The position peaked at $23K in Q2 2022. 4 funds tracked by Wall St. Rank hold GLS.WS as of Q1 2023.

  • Cowen and Company reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 702,089 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2023, an estimated $6.25K.
  • Cowen and Company first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q2 2022 and held it in 3 quarters.
  • Cowen and Company's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $23K in Q2 2022.
  • 4 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.